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The ApxIIA protein secreted from ActinobaciUlus pleuropneumoniae is both hemolytic and cytotoxic. However,
when the cloned apxII operon is expressed in Escherichia coli, two forms of the ApxIIA protein can be recovered.
Toxin which remains intracellular has hemolytic and cytotoxic activities, while toxin that is secreted is cytotoxic
with little or no hemolytic activity. This indicates that the cytotoxicity ofApxILA is independent of its hemolytic
activity.
Actinobacillus pleuropneumoniae is one of a number of
gram-negative bacteria that secrete toxins of the RTX (repeat
toxin) family (15). To date, three antigenically different RTXs
have been found to be produced by different A. pleuropneu-
moniae isolates singly or in combination (6, 10). The genetic
determinants for each of these three toxins (ApxI, ApxII, and
ApxIII) have been cloned and sequenced (2, 3, 7). Neutraliza-
tion studies with monoclonal antibodies (10) and direct mea-
surements of the lytic activity of the recombinant toxins
expressed in Escherichia coli (2, 3, 7) have shown that these
three toxins are functionally distinct. ApxIA displays the
strongest hemolytic and cytotoxic activity. ApxIIA is also
hemolytic and cytotoxic but is claimed to have a lower level of
specific activity than ApxIA (10). ApxIIIA, like LktA produced
by Pasteurella haemolytica and AaLktA from Actinobacillus
actinomycetemcomitans, is cytotoxic but not hemolytic and thus
belongs to the leukotoxin class of the RTX family (2).
The genetic determinants for the prototypical RTX consist
of four genes, CABD, expressed from a common promoter or
promoters (15). The A gene encodes the protoxin protein,
which requires activation to display its full lytic activity. The
activating event appears to be an RTX C-dependent acylation
with a long chain fatty acid (8, 9). The exact number of sites for
acylation of the protoxin and their location are not known for
any of the RTX A proteins. In addition, the temporal relation-
ship between synthesis, acylation, and secretion is also un-
known. The RTX BD genes encode proteins which have been
localized to the bacterial envelope and are required for
secretion. For a-hemolysin, an RTX normally expressed by
certain strains of E. coli, at least three additional genes appear
to be required for secretion of active toxin: (i) acpP, which
encodes acyl carrier protein, the putative acyl donor for
activation of the protoxin in vitro (9); (ii) tolC, which is
required for secretion (13); and (iii) rfaH, which has been
variously claimed to be necessary for transcription of the hly
genes (1), secretion of a-hemolysin from E. coli (14), or
activation of the prohemolysin protein (4). Thus, the secretion
of an active RTX is likely to be more complicated than
originally envisioned, involving the products of at least seven
different genes.
* Corresponding author. Mailing address: Department of Medical
Biochemistry and Genetics, Texas A&M University Health Science
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1114. Phone: (409) 845-9416. Fax: (409) 847-9481.
We have previously reported the cloning of the apxIICA
genes from A. pleuropneumoniae and the production of hemo-
lytically active ApxIIA protein in E. coli (3). In this note, we
report that the ApxIIA protein recovered from cultures of E.
coli expressing the apxIICA genes appears to exist in two forms
which differ markedly in their relative hemolytic and cytotoxic
activities.
The ApxIIA protein has been reported to be moderately
cytotoxic and weakly hemolytic (10). To make a quantitative
comparison of these two activities of ApxIIA, we prepared
culture supernatants from an A. pleuropneumoniae serotype 7
isolate grown in brain heart infusion broth supplemented with
0.01% NAD. Serotype 7 strains have been shown to secrete
only the ApxIIA protein and do not contain the genes for
ApxIA or ApxIIIA toxins (6, 10). Using bovine erythrocytes
and cells from the bovine leukemic cell line BL3 as target cells,
we found the ApxIIA toxin secreted byA. pleuropneumoniae to
be nearly equipotent on a per-target-cell basis in its ability to
lyse these two cell types (Fig. 1). The ratio of hemolytic to
cytotoxic activity was invariant during culture growth, with the
highest absolute titers occurring as the culture entered the
stationary phase (data not shown).
When the apxIICA genes are expressed in E. coli in the
absence of RTX BD gene function, lytically active ApxIIA
protein accumulates intracellularly and can only be detected
after lysis of the bacterial cells by passage through a French
pressure cell (3). Intracellular toxin activity peaks at late-log
phase and rapidly disappears as the culture enters stationary
phase, presumably because of the degradation or denaturation
of the accumulated ApxIIA protein (Fig. 2). The ratio of
hemolytic to cytolytic activity of the intracellular toxin is
approximately 0.5 when assayed against bovine erythrocytes
and BL3 leukocytes (Fig. 1). The ratio of intracellular hemo-
lytic to cytolytic activity observed in E. coli is unchanged when
RTX BD genes are expressed in trans to apxIICA (compare
Fig. 1B and 2B). Thus, the activity of the recombinant toxin
recovered from the E. coli cytoplasm appears similar to that
secreted by A. pleuropneumoniae. Intracellular hemolytic and
cytolytic activities are observed only when apxIIC and apxIIA
are expressed in the same cell. Mixing lysates from cultures in
which the two cloned genes were expressed separately does not
result in lytic activity against either of the two target cell types.
When E. coli cells harboring pYFC37 (apxIICA) and either
pLG575 (hlyBD), pYFC65 (apxIBD), or pHT55 (lktBD) are
plated onto blood agar, the resulting colonies develop small
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FIG. i. Lytic activity of the ApxIIA toxin. The toxin was assayed
against bovine erythrocytes (solid circles) or bovine leukemia cell line
BL3 (open circles), as previously described (11). (A) ApxIIA secreted
from a serotype 7 isolate ofA. pleuropneumoniae exhibiting 50% lethal
dose (LD50) values of 100 U/ml for erythrocytes and 50 U/ml for BL3
cells. (B) Intracellular ApxIIA toxin, which accumulates within E. coli
when the apxIICA genes are expressed in the absence of RTX BD
function, yielding LD50 values of 100 U/[Lg of lysate protein for
erythrocytes and 200 U/,ug of lysate protein for BL3 cells.
zones of partial hemolysis around their peripheries, suggesting
the secretion of hemolytically active ApxIIA. However, when
grown in liquid media, no hemolytic activity can be found in
cell-free culture supernatants collected in the early, mid, or
late phases of logarithmic growth or in the stationary fhase(Fig. 2). In contrast, lytic activity against the BL3 cell line is
easily detected and peaks at the mid- to late-log phase,
approximately the time at which the highest levels of intracel-
lular activity are found (Fig. 2). Even when culture superna-
tants are concentrated 50-fold by ammonium sulfate precipi-
tation, no hemolytic activity can be detected, despite the fact
that cytolytic activity is concentrated >20-fold by this proce-
dure (data not shown). This raises the possibility that the
intracellular hemolytic activity we attributed to ApxIIA was
actually due to E. coli-specific components of the lysate
complexing to hemolytically inactive ApxIIA. To control for
this, the secreted form of the toxin was mixed with lysates
prepared from E. coli cells harboring either the vector pAC18
(11) or pDM44, which contains the apxIIC gene expressed
from the lac promoter of pAC18. In neither case could
hemolytic activity be conferred upon the secreted ApxIIA
protein. Thus, it would appear that the recombinant ApxIIA
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FIG. 2. Lytic activity of the intracellular and secreted forms of the
ApxIIA protein from E. coli. E. coli host cells expressing the apxIICA
and lktBD genes were grown to late log phase (0), and the presence of
extracellular and intracellular toxin was assessed periodically by assays
with erythrocytes (A) and the BL3 cell line (-). Fifty percent lethal
dose (LD50) values were determined from lysis curves similar to those
shown in Fig. 1 for the indicated time points. (A) Secreted toxin. (B)
Intracellular toxin. OD550, optical density at 550 nm.
protein expressed in E. coli can be recovered in two forms: (i)
an intracellular form whose hemolytic and cytotoxic activities
are comparable to those of the ApxIIA toxin secreted by A.
pleuropneumoniae and (ii) an extracellular form which is
cytotoxic with little or no hemolytic activity. It is likely that the
intracellular toxin is a mixture of the two forms, so that its
hemolytic/cytotoxic ratio is lower than that of ApxIIA secreted
from A. pleuropneumoniae (Fig. 1).
The inability of E. coli to secrete recombinant ApxIIA
protein with a hemolytic/cytotoxic activity ratio similar to that
which accumulates intracellularly can be explained in one of
two ways. First, it is possible that the ApxIIC-dependent
activation of pro-ApxIIA is a multistep process and an inter-
mediate form of the toxin with cytolytic, but not hemolytic,
properties can be efficiently secreted while the fully activated
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TABLE 1. Effect of renaturation from guanidine hydrochloride on
activity of secreted toxins
LD5() U'7ml of culture supernatant
Source of secreted Crude supernatant After renaturation'
ApxllA toxin"
Hemolytic Cytotoxic Hemolytic Cytotoxic
titer titer titer titer
A. pleuropneumoniae 114 83 400 266
E. coli NDd 100 ND 500
Cultures were grown to an optical density at 550 nm of approximately 1.7.
h One LD5() unit is the amount of culture supernatant required to achieve 501%
lysis of 107 input cells.
' Culture supernatants were precipitated and renatured from guanidine hy-
drochloride as described previously (12).
d ND, no hemolytic activity detected (<I LD50 U/ml).
toxin is inefficiently secreted from the heterologous host.
Alternatively, activation of pro-ApxIIA may occur in a single
step, but, during the secretory process, the conformation of the
toxin is altered so that its hemolytic activity is lost. These
distinct models cannot be differentiated until analytical proce-
dures are developed to separate the ApxIIA protein into its
chemical or conformational isomers. Recently, it has been
found that defects in lipopolysaccharide formation can lead to
the secretion of an inactive form of ox-hemolysin which be-
comes hemolytically active after renaturation from 4 M guani-
dine hydrochloride (12). However, this phenomenon seems
unrelated to that reported here, since the ApxIIA toxin
secreted by E. coli does not regain hemolytic activity after
exposure to denaturants even though its cytotoxicity to BL3
cells is enhanced by this procedure (Table 1). In any case, the
findings reported here confirm previous reports (5, 11) that the
hemolytic and cytotoxic activities of the RTX hemolysins are
independent of each other.
This work was supported by USDA Competitive Research grant
92-37204-7954 to D.K.S. and R.Y.
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